September 22 - 25, 2022   Chicago Marriott Downtown Magnificent Mile


All times listed are Central Time Zone.

Thursday, September 22

9:00 AM Welcome
William Gradishar, MD
Future Issues in Breast Cancer
Session Chair: Nora Hansen, MD
9:10 AM AI in Breast Imaging
Linda Moy, MD
9:40 AM AI in Pathology
Matthew Hanna, MD
10:10 AM Minimal Residual Disease: Assessment and Implications
Pedram Razavi, MD, PhD
10:40 AM Cardiac Issues Related to Breast Cancer RX
Nausheen Akhter, MD
11:10 AM Q&A
11:40 AM Break, Exhibits, and Lunch
Breast Pathology for the Non-Pathologist
Session Chair: Kalliopi Siziopikou, MD, PhD
1:00 PM HER2-Low Breast Cancer: Current Progress and Remaining Challenges
Kalliopi Siziopikou, MD, PhD
1:30 PM Updates in the Pathology of Pregnancy Associated Breast Cancer
Luis Blanco Jr., MD
2:00 PM Prognostic and Predictive Factors in Breast Cancer
Hannah Wen, MD, PhD
2:30 PM Molecular Biomarkers and Genomic Assays in Breast Cancer
Virginia Kaklamani, MD, DSc
3:00 PM Q&A
3:20 PM Break
3:40 PM Unusual Cases
William Gradishar, MD & confirmed faculty
4:30 PM Adjourn Day 1
4:45 PM Opening Reception

View more agendas: Thursday | Friday | Saturday | Sunday

Friday, September 23

Imaging & Risk
Session Chair: Seema Khan, MD
8:30 AM Moderate Penetrance Genes: Risk Level and Management Strategies
Claudine Isaacs, MD
9:00 AM Surgery in Genetically Induced Breast Cancer
Seema Khan, MD
9:30 AM Genetic Risk Evaluation of Patient and Family Members: Practice vs Promise
Steven Katz, MD, MPH
10:00 AM Break
10:20 AM What’s New in Non-Genetic Risk?
Melissa Pilewskie, MD
10:50 AM Update Enhanced Contrast Enhanced Mammography
Maxine Jochelson, MD
11:20 AM Q&A
11:45 AM Break, Exhibits, and Lunch
Triple Negative Breast Cancer (TNBC) and Advanced Diagnosis
Session Chair: Swati Kulkarni, MD
1:10 PM Enhancing Adjuvant Therapy of TNBC
Hope Rugo, MD
1:40 PM Special Subtypes of TNBC
Stuart Schnitt, MD
2:10 PM Metastatic TNBC
Lisa Carey, MD
2:40 PM Surgical Issues in Advanced Breast Cancer
Audree Tadros, MD, MPH
3:10 PM Break
3:30 PM Axillary Surgery After Neoadjuvant Therapy
Tracy-Ann Moo, MD
4:00 PM Q&A
4:30 PM Adjourn Day 2

View more agendas: Thursday | Friday | Saturday | Sunday

Saturday, September 24

Management of ER+ Disease
Session Chair: William Gradishar, MD
8:30 AM Adjuvant Therapy of ER+ Breast Cancer
Kevin Kalinsky, MD, MS
9:00 AM SERDs and Beyond
Erika Hamilton, MD
9:30 AM Infiltrating Lobular Carcinoma
Tari King, MD
10:00 AM Neoadjuvant Endocrine Therapy
Otto Metzger, MD
10:30 AM Q&A
11:00 AM Break
Breast Cancer: Advances over Three Decades and Future Potential
Eric Winer, MD
12:20 PM Break, Exhibits, and Lunch
Controversies in HER2+ Breast Cancer
Session Chair: Jonathan Strauss, MD, MBA
1:30 PM Adjuvant/Neoadjuvant Therapy of HER2+ Early Breast Cancer
Sarah Tolaney, MD
2:00 PM Triple Positive Breast Cancer
Sara Hurvitz, MD
2:30 PM Sequencing of HER2 Therapy in Metastatic Breast Cancer
William Gradishar, MD
3:00 PM Management of Oligometastatic Disease
Jonathan Strauss, MD, MBA
3:30 PM Q&A
4:00 PM Case Management Panel
Moderator: Monica Morrow, MD
5:15 PM Adjourn Day 3

View more agendas: Thursday | Friday | Saturday | Sunday

Sunday, September 25

Unresolved Problems
Session Chair: Monica Morrow, MD
8:30 AM Radiation Therapy Scheduling: Which is Best?
Julia White, MD
9:00 AM Understanding Risk Factors for Lymphedema Development after ALND
Andrea Barrio, MD
9:30 AM Evolving Role of Axillary Surgery
Monica Morrow, MD
10:00 AM Lumpectomy Re-Visited 2022
Armando Guiliano, MD
10:30 AM Q&A
11:00 AM Adjourn Day 4

View more agendas: Thursday | Friday | Saturday | Sunday


There will be no breakout sessions in 2020

View more agendas: Thursday | Friday | Saturday | Sunday


The Lurie Cancer Center's Lynn Sage Breast Cancer Symposium offers 3 days of formal presentations and interactive Q&A sessions.


The Lynn Sage Breast Cancer Symposium is proud of its tradition of attracting a faculty comprised of experts from around the world. Faculty list


Optional, non-CME educational activities are scheduled during times that do not conflict with the Symposium agenda.

Details »

© 2022 Robert H. Lurie Comprehensive Cancer Center